Unknown

Dataset Information

Prognosis of late elderly patients with chronic hepatitis C after achieving a sustained viral response by direct-acting antivirals.


ABSTRACT:

Background and aim

We investigated the prognosis of late elderly patients (≥75 years old) after the achievement of a sustained viral response (SVR) by direct-acting antivirals (DAAs).

Methods

One hundred and four late elderly patients and 251 young patients (≤74 years old) who had achieved an SVR were included. We compared the cumulative hepatocellular carcinoma (HCC) incidence rates and survival rates after DAA administration. Furthermore, the factors associated with HCC incidence and the causes of death after DAA administration were also investigated.

Results

The cumulative HCC incidence rates for 1 and 3 years were 2.9% and 11.7% in the late elderly patients and 2.4% and 5.4% in the young patients, respectively. The cumulative survival rates for 1 and 3 years were

SUBMITTER: Takakusagi S 

PROVIDER: S-EPMC7812467 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature